News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
263,103 Results
Type
Article (13696)
Company Profile (110)
Press Release (249297)
Section
Business (88295)
Career Advice (467)
Deals (15401)
Drug Delivery (64)
Drug Development (36596)
Employer Resources (49)
FDA (6288)
Job Trends (6218)
News (150577)
Policy (14086)
Tag
Academia (449)
Alliances (23207)
Alzheimer's disease (360)
Approvals (6286)
Artificial intelligence (66)
Bankruptcy (143)
Best Places to Work (4366)
Biotechnology (45)
Breast cancer (56)
Cancer (384)
Career advice (409)
Cell therapy (54)
Clinical research (30552)
Collaboration (180)
Compensation (74)
COVID-19 (749)
C-suite (56)
Data (416)
Diabetes (56)
Diagnostics (1249)
Drug pricing (58)
Earnings (31705)
Employer resources (43)
Events (37033)
Executive appointments (195)
FDA (6496)
Funding (120)
Gene therapy (62)
GLP-1 (299)
Government (1292)
Healthcare (3570)
Infectious disease (767)
Inflammatory bowel disease (48)
Interviews (59)
IPO (5856)
Job creations (2056)
Job search strategy (376)
Layoffs (167)
Legal (3422)
Lung cancer (51)
Manufacturing (104)
Medical device (1296)
Medtech (1298)
Mergers & acquisitions (9601)
Metabolic disorders (178)
Neuroscience (469)
NextGen Class of 2024 (1597)
Non-profit (601)
Northern California (478)
Obesity (109)
Opinion (109)
Patents (60)
People (28592)
Pharmaceutical (67)
Phase I (7945)
Phase II (12920)
Phase III (11618)
Pipeline (197)
Policy (45)
Postmarket research (1399)
Preclinical (3192)
Radiopharmaceuticals (116)
Rare diseases (100)
Real estate (2651)
Regulatory (9899)
Research institute (572)
Resumes & cover letters (55)
Southern California (472)
Startups (1630)
United States (4669)
Vaccines (114)
Weight loss (80)
Date
Today (51)
Last 7 days (226)
Last 30 days (1002)
Last 365 days (12625)
2024 (12205)
2023 (14309)
2022 (19634)
2021 (20179)
2020 (19149)
2019 (15037)
2018 (11829)
2017 (13945)
2016 (13185)
2015 (15535)
2014 (12461)
2013 (10652)
2012 (11440)
2011 (11984)
2010 (10935)
Location
Africa (314)
Arizona (43)
Asia (19921)
Australia (2568)
California (1112)
Canada (648)
China (130)
Colorado (45)
Connecticut (46)
Europe (38999)
Florida (170)
Illinois (123)
Indiana (94)
Japan (48)
Kansas (51)
Maryland (165)
Massachusetts (963)
Minnesota (62)
New Jersey (473)
New York (302)
North Carolina (285)
Northern California (478)
Pennsylvania (305)
South America (505)
Southern California (472)
Texas (155)
Virginia (43)
Washington State (74)
263,103 Results for "aqua pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Neurophet to Participate in RSNA 2024: Unveiling Multiple Sclerosis Analysis Technology with Neurophet AQUA
December 5, 2024
·
3 min read
Press Releases
Neurophet Secures FDA 510(k) Clearance for Multiple Sclerosis Analysis with ‘Neurophet AQUA’
November 25, 2024
·
3 min read
Deals
Elanco Announces Sale of Aqua Business for $1.3 Billion
Elanco Animal Health Incorporated announced it has entered into an agreement to sell its aqua business to Merck Animal Health for approximately $1.3 billion in cash, which represents approximately 7.4x the estimated 2023 revenue of the Elanco aqua business.
February 5, 2024
·
8 min read
Deals
Merck Animal Health to Acquire Elanco’s Aqua Business
Merck Animal Health announced that it has signed a definitive agreement to acquire the aqua business of Elanco Animal Health Incorporated for $1.3 billion in cash, consisting of an innovative portfolio of medicines and vaccines, nutritionals and supplements for aquatic species.
February 5, 2024
·
7 min read
Press Releases
Neurophet to launch total solution for AD treatments ‘Neurophet AQUA AD’ at AAIC 2024
July 25, 2024
·
3 min read
Neurophet receives FDA 510(k) Clearance for Neurophet AQUA
Neurophet, an artificial intelligence (AI) solution company for brain disease, announced that the US Food and Drug Administration (FDA) 510(k) has cleared “Neurophet AQUA”.
May 18, 2023
·
3 min read
Aqua-Yield Announces $23 Million Series A Funding Round
Aqua-Yield, the leading nanoliquid company for agricultural production worldwide, today announced the close of its Series A investment round of $23M.
September 13, 2022
·
5 min read
Press Releases
AquaBounty Technologies Announces Third Quarter 2024 Financial Results
November 5, 2024
·
12 min read
Layoffs
Marinus Pharmaceuticals Lays Off 45% of Employees
The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.
November 14, 2024
·
1 min read
·
Angela Gabriel
Business
David F. Melbourne Jr. Promoted to Chief Executive Officer of AquaBounty; Sylvia Wulf to Continue as Non-Executive Board Chair
The Board of Directors of AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability
June 7, 2024
·
8 min read
1 of 26,311
Next
